Benzinga | Nov 9, 2021 11:27AM EST

Haemonetics Q2 Adj. EPS $0.60 Misses $0.61 Estimate, Sales $239.90M Miss $241.40M Estimate

Haemonetics (NYSE:HAE) reported quarterly earnings of $0.60 per share which missed the analyst consensus estimate of $0.61 by 1.64 percent. This is a 3.23 percent decrease over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $239.90 million which missed the analyst consensus estimate of $241.40 million by 0.62 percent. This is a 14.52 percent increase over sales of $209.49 million the same period last year.